Extracellular vesicles (EVs) are esteemed as a promising delivery vehicle for various genetic therapeutics. They are relatively inert, non-immunogenic, biodegradable, and biocompatible...
Read More »EXOSOME NEWS
$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy
VivaZome Therapeutics is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the...
Read More »Cellular messengers improve cancer therapy
Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint...
Read More »Single-cell transcriptomics reveal extracellular vesicles secretion with a cardiomyocyte proteostasis signature during pathological remodeling
Aberrant Wnt activation has been reported in failing cardiomyocytes. Researchers at University Medical Center Göttingen present single cell transcriptome profiling of hearts with inducible cardiomyocyte-specific Wnt activation (β-catΔex3) as well as with...
Read More »Triple study exploits cellular messengers for diagnostics and drug delivery
In a series of three papers on extracellular vesicles (EVs) — particles that cells use to communicate — Skoltech researchers and their colleagues have...
Read More »Nanoscopic tool assesses alternative COVID-19 prevention
Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy can be used to assess the effectivity of spike-neutralizing antibodies for preventing COVID-19. The use of...
Read More »Upcoming Digital Conference – Applications of Exosomes
Exosomes RNA are pleased to announce that we are an official media partner of Applications of Exosomes. Returning for another year on March 29-30, 2023, this hugely successful 2-day digital...
Read More »Early-career investigator wins award for exosome research
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Miguel Flores-Bellver, PhD, recipient of the 2023 Bert M. Glaser, MD Award for Innovative Research in...
Read More »An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
Despite significant therapeutic advances, lung cancer remains the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) patients have a very poor overall five-year survival rate of...
Read More »DNA Nanomaterial-Based Optical Probes for Exosomal miRNA Detection
Micro ribonucleic acids (miRNAs) in exosomes have been proven as reliable biomarkers to detect disease progression. In recent years, deoxyribonucleic acid...
Read More »Jobs
-
Post-doc Position Available – Cancer and Infectious Disease Biomarkers
The Postdoctoral Fellow for the Department of Biochemistry and Molecular Biology will be responsible for molecular biology and bioengineering-based new technologies and approaches to detect and measure biomarkers associated...
Read More » -
Featured Exosomes Job – Production Specialist In Extracellular Vesicles
-
Featured Exosome Job – Assistant Professor/Associate Professor/Professor – Exosome Biology, Biomimetics and Immunotherapy
-
PhD Opportunity – Stem Cell Exosomes – Important Communicators with Therapeutic Potential in the Dental Pulp
-
Post-doc position available – Faculty of Dentistry
Industry News
-
Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research
Study to investigate effectiveness of early-stage pancreatic cancer detection using patented exosome-isolation technology Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center ...
Read More » -
Creative Biolabs: Wishing a Year of Prosperity for Exosome Studies
-
NeuroDex receives MJFF grant to study blood test for Parkinson’s stratification based on extracellular vesicles
-
MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award
-
$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy